Differential spatial approximation between cholecystokinin residue 30 and receptor residues in active and inactive conformations

Maoqing Dong, Elizabeth M. Hadac, Delia I. Pinon, Laurence J Miller

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Understanding the structures of active and inactive agonist-and antagonist-bound receptor complexes is of great interest. In this work, we focus on position 30 of cholecystokinin (CCK) and its spatial approximation with the type A CCK receptor. For this, we developed two photoaffinity labeling probes, replacing the naturally occurring tryptophan with p-benzoyl-L-phenylalanine (Bpa) or p-nitro-phenylalanine (NO2-Phe). The Bpa probe was shown to represent an antagonist, whereas the NO2-Phe probe stimulated intracellular calcium as a fully efficacious agonist (EC50 = 81 ± 15 nM). Both ligands bound to the receptor specifically, although with lower affinity than CCK (Ki values: Bpa probe, 270 ± 72 nM; NO2-Phe probe, 180 ± 40 nM). Both probes covalently labeled the receptor in an efficient manner. The Bpa antagonist labeled the receptor in two distinct regions as identified by cyanogen bromide cleavage, with labeled bands migrating at Mr = 25,000 and 4500. The former represented the glycosylated amino-terminal fragment, with the site of attachment further localized by endoproteinase Lys-C cleavage to the region between Asn 10 and Lys37. The latter was shown to represent the first extracellular loop using further cleavage and sequencing of the wild-type and a mutant receptor. Following the same approach, the NO2-Phe agonist probe was shown to also label the first extracellular loop region. Radiochemical sequencing identified that the Bpa antagonist probe labeled receptor residue Lys105, whereas the NO2-Phe agonist probe labeled residue Leu99. These data extend our understanding of the molecular basis of binding and the conformational states of this important receptor.

Original languageEnglish (US)
Pages (from-to)1892-1900
Number of pages9
JournalMolecular Pharmacology
Volume67
Issue number6
DOIs
StatePublished - Jun 2005

Fingerprint

Cholecystokinin
Phenylalanine
Cholecystokinin A Receptor
Cyanogen Bromide
Tryptophan
Ligands
Calcium

ASJC Scopus subject areas

  • Pharmacology

Cite this

Differential spatial approximation between cholecystokinin residue 30 and receptor residues in active and inactive conformations. / Dong, Maoqing; Hadac, Elizabeth M.; Pinon, Delia I.; Miller, Laurence J.

In: Molecular Pharmacology, Vol. 67, No. 6, 06.2005, p. 1892-1900.

Research output: Contribution to journalArticle

@article{4bee0225a0d3467998cc2bf6f17076a5,
title = "Differential spatial approximation between cholecystokinin residue 30 and receptor residues in active and inactive conformations",
abstract = "Understanding the structures of active and inactive agonist-and antagonist-bound receptor complexes is of great interest. In this work, we focus on position 30 of cholecystokinin (CCK) and its spatial approximation with the type A CCK receptor. For this, we developed two photoaffinity labeling probes, replacing the naturally occurring tryptophan with p-benzoyl-L-phenylalanine (Bpa) or p-nitro-phenylalanine (NO2-Phe). The Bpa probe was shown to represent an antagonist, whereas the NO2-Phe probe stimulated intracellular calcium as a fully efficacious agonist (EC50 = 81 ± 15 nM). Both ligands bound to the receptor specifically, although with lower affinity than CCK (Ki values: Bpa probe, 270 ± 72 nM; NO2-Phe probe, 180 ± 40 nM). Both probes covalently labeled the receptor in an efficient manner. The Bpa antagonist labeled the receptor in two distinct regions as identified by cyanogen bromide cleavage, with labeled bands migrating at Mr = 25,000 and 4500. The former represented the glycosylated amino-terminal fragment, with the site of attachment further localized by endoproteinase Lys-C cleavage to the region between Asn 10 and Lys37. The latter was shown to represent the first extracellular loop using further cleavage and sequencing of the wild-type and a mutant receptor. Following the same approach, the NO2-Phe agonist probe was shown to also label the first extracellular loop region. Radiochemical sequencing identified that the Bpa antagonist probe labeled receptor residue Lys105, whereas the NO2-Phe agonist probe labeled residue Leu99. These data extend our understanding of the molecular basis of binding and the conformational states of this important receptor.",
author = "Maoqing Dong and Hadac, {Elizabeth M.} and Pinon, {Delia I.} and Miller, {Laurence J}",
year = "2005",
month = "6",
doi = "10.1124/mol.105.012179",
language = "English (US)",
volume = "67",
pages = "1892--1900",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "6",

}

TY - JOUR

T1 - Differential spatial approximation between cholecystokinin residue 30 and receptor residues in active and inactive conformations

AU - Dong, Maoqing

AU - Hadac, Elizabeth M.

AU - Pinon, Delia I.

AU - Miller, Laurence J

PY - 2005/6

Y1 - 2005/6

N2 - Understanding the structures of active and inactive agonist-and antagonist-bound receptor complexes is of great interest. In this work, we focus on position 30 of cholecystokinin (CCK) and its spatial approximation with the type A CCK receptor. For this, we developed two photoaffinity labeling probes, replacing the naturally occurring tryptophan with p-benzoyl-L-phenylalanine (Bpa) or p-nitro-phenylalanine (NO2-Phe). The Bpa probe was shown to represent an antagonist, whereas the NO2-Phe probe stimulated intracellular calcium as a fully efficacious agonist (EC50 = 81 ± 15 nM). Both ligands bound to the receptor specifically, although with lower affinity than CCK (Ki values: Bpa probe, 270 ± 72 nM; NO2-Phe probe, 180 ± 40 nM). Both probes covalently labeled the receptor in an efficient manner. The Bpa antagonist labeled the receptor in two distinct regions as identified by cyanogen bromide cleavage, with labeled bands migrating at Mr = 25,000 and 4500. The former represented the glycosylated amino-terminal fragment, with the site of attachment further localized by endoproteinase Lys-C cleavage to the region between Asn 10 and Lys37. The latter was shown to represent the first extracellular loop using further cleavage and sequencing of the wild-type and a mutant receptor. Following the same approach, the NO2-Phe agonist probe was shown to also label the first extracellular loop region. Radiochemical sequencing identified that the Bpa antagonist probe labeled receptor residue Lys105, whereas the NO2-Phe agonist probe labeled residue Leu99. These data extend our understanding of the molecular basis of binding and the conformational states of this important receptor.

AB - Understanding the structures of active and inactive agonist-and antagonist-bound receptor complexes is of great interest. In this work, we focus on position 30 of cholecystokinin (CCK) and its spatial approximation with the type A CCK receptor. For this, we developed two photoaffinity labeling probes, replacing the naturally occurring tryptophan with p-benzoyl-L-phenylalanine (Bpa) or p-nitro-phenylalanine (NO2-Phe). The Bpa probe was shown to represent an antagonist, whereas the NO2-Phe probe stimulated intracellular calcium as a fully efficacious agonist (EC50 = 81 ± 15 nM). Both ligands bound to the receptor specifically, although with lower affinity than CCK (Ki values: Bpa probe, 270 ± 72 nM; NO2-Phe probe, 180 ± 40 nM). Both probes covalently labeled the receptor in an efficient manner. The Bpa antagonist labeled the receptor in two distinct regions as identified by cyanogen bromide cleavage, with labeled bands migrating at Mr = 25,000 and 4500. The former represented the glycosylated amino-terminal fragment, with the site of attachment further localized by endoproteinase Lys-C cleavage to the region between Asn 10 and Lys37. The latter was shown to represent the first extracellular loop using further cleavage and sequencing of the wild-type and a mutant receptor. Following the same approach, the NO2-Phe agonist probe was shown to also label the first extracellular loop region. Radiochemical sequencing identified that the Bpa antagonist probe labeled receptor residue Lys105, whereas the NO2-Phe agonist probe labeled residue Leu99. These data extend our understanding of the molecular basis of binding and the conformational states of this important receptor.

UR - http://www.scopus.com/inward/record.url?scp=21744435941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21744435941&partnerID=8YFLogxK

U2 - 10.1124/mol.105.012179

DO - 10.1124/mol.105.012179

M3 - Article

C2 - 15774770

AN - SCOPUS:21744435941

VL - 67

SP - 1892

EP - 1900

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 6

ER -